PCR Technologies Market by Technology (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene expression, diagnostics), Enduser (Academia, pharma-biotech, applied)-Global Forecast to 2025

世界のPCR技術市場予測:技術別、製品別、用途別、エンドユーザー別

◆タイトル:PCR Technologies Market by Technology (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene expression, diagnostics), Enduser (Academia, pharma-biotech, applied)-Global Forecast to 2025
◆商品コード:AST7880
◆調査・発行会社:MarketsandMarkets
◆発行日:2029年4月23日
◆ページ数:194
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥731,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥896,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

マーケッツアンドマーケッツ社は、世界のPCR技術市場規模が2020年72億ドルから2025年98億ドルまで、年平均6.3%成長すると予測しています。本調査レポートでは、PCR技術の世界市場を調査対象とし、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、技術別(従来型PCR、リアルタイムPCR、デジタルPCR、逆転写PCR、ホットスタートPCR)分析、製品別(機器、試薬&消耗品、ソフトウェア&サービス)分析、用途別(遺伝子発現解析、遺伝子配列決定、ジェノタイピング、核酸検出、核酸合成)分析、エンドユーザー別(病院&診断研究所、医療産業、学術&政府機関、製薬&バイオテクノロジー、産業応用)分析、地域別分析、競争状況、企業情報などを整理しました。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界のPCR技術市場規模:技術別(従来型PCR、リアルタイムPCR、デジタルPCR、逆転写PCR、ホットスタートPCR)
・世界のPCR技術市場規模:製品別(機器、試薬&消耗品、ソフトウェア&サービス)
・世界のPCR技術市場規模:用途別(遺伝子発現解析、遺伝子配列決定、ジェノタイピング、核酸検出、核酸合成)
・世界のPCR技術市場規模:エンドユーザー別(病院&診断研究所、医療産業、学術&政府機関、製薬&バイオテクノロジー、産業応用)
・世界のPCR技術市場規模:地域別
・競争状況
・企業情報

“The global PCR technologies market is projected to reach USD 9.8 billion by 2025 from USD 7.2 billion in 2020, at a CAGR of 6.3% from 2020 to 2025.”
The rising incidence of infectious diseases and genetic disorders across the world has spurred the demand for better and faster diagnostic tests. This has also boosted the overall pace of R&D in the PCR technologies market along with the availability of strong financial support in the form of investments, funds, and grants. These factors are driving the growth of PCR technologies market during the forecast period. However, high instrument costs—especially that of dPCR—and the technical limitations of PCR are expected to limit market growth to a certain extent.

“The qPCR segment is expected to account for the largest market share of the global PCR technologies market in 2020.”
The qPCR segment is expected to account for the largest share among PCR techniques in 2020. The expanding applications of qPCR (owing to its technological benefits over traditional PCR, such as real-time analysis and reduced analysis time), growing private-public funding for life sciences research, and the rising number of probe-based multiplex genetic analysis procedures (that require the analysis of low-volume gene samples) are expected to drive the growth of the qPCR market.

“Reagents and consumables segment to show the highest growth in the PCR technologies market during the forecast period.”
The reagents and consumables segment will show the highest growth in the PCR technologies market during the forecast period. The growth of this segment can be attributed to factors such as the expanding applications of dPCR, the increasing number of dPCR-based analytical procedures among institutional researchers (such as CROs and pharma-biotech companies), and the rising availability of novel dPCR reagents worldwide. Additionally, the expansion of the application base of the dPCR technology in genetic/molecular research, clinical diagnosis, and forensics is expected to result in the commercialization of novel dPCR reagents.

“North America to account for the largest share of the global market in 2020.”
North America accounts for the largest share of the PCR technologies market owing to the high incidence of chronic and genetic diseases, rising geriatric population, growing adoption of PCR techniques in research & academia, and significant public-private funding in the field of genome analysis. Further, the strong presence of major pharmaceutical and biotechnology companies in the US and ongoing initiatives by the Canadian government to support life science, genomic, and clinical research are other few factors influencing the demand for PCR products in this region

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 – 48%, Tier 2: 36%, and Tier 3: 16%
• By Designation: C-level 10%, D-level: 14%, and Others: 76%
• By Region: North America: 40%, Europe: 32%, APAC: 20%, Latin America: 5%, and the Middle East & Africa: 3%

The major players in the market include Abbott Laboratories (US), Agilent Technologies, Inc. (US), Analytik Jena AG (Germany), Becton Dickinson and Company (US), bioMérieux S.A. (France), Bio-Rad Laboratories, Inc. (US), Danaher Corporation (US), Eppendorf AG (Germany), F. Hoffman-La Roche Ltd. (Switzerland), Fluidigm Corporation (US), Merck KGaA (Germany), Promega Corporation (US), QIAGEN N.V. (Germany), Takara Bio, Inc. (Japan), and Thermo Fisher Scientific, Inc. (US).

Research Coverage
This report studies the PCR technologies market based on product and services, application, end user, and region. The report also studies factors such as drivers, restraints, opportunities, and challenges affecting the market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions and the respective countries in these regions.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market shares of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the market, and high-growth regions, as well as their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.2.1 INCLUSIONS & EXCLUSIONS 25
1.3 STUDY SCOPE 25
1.3.1 MARKETS COVERED 25
1.3.2 YEARS CONSIDERED FOR THE STUDY 26
1.4 CURRENCY USED FOR THE STUDY 26
1.5 MARKET STAKEHOLDERS 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
FIGURE 1 RESEARCH DESIGN 27
2.1.1 SECONDARY DATA 28
2.1.1.1 Key data from secondary sources 29
2.1.2 PRIMARY DATA 30
FIGURE 2 BREAKDOWN OF PRIMARIES: PCR TECHNOLOGIES MARKET 30
2.2 MARKET ESTIMATION METHODOLOGY 30
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 31
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION 31
2.2.2 USAGE-BASED MARKET ESTIMATION 32
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL PCR
TECHNOLOGIES MARKET 32
2.2.3 PRIMARY RESEARCH VALIDATION 32
2.3 DATA TRIANGULATION 33
FIGURE 5 DATA TRIANGULATION 33
2.4 RESEARCH ASSUMPTIONS 34
2.5 RESEARCH LIMITATIONS 34
3 EXECUTIVE SUMMARY 35
FIGURE 6 PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE,
2020 VS. 2025 (USD MILLION) 35
FIGURE 7 PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2020 VS. 2025 (USD MILLION) 36
FIGURE 8 PCR TECHNOLOGIES MARKET, BY END USER, 2020 VS. 2025 (USD MILLION) 36
FIGURE 9 APAC MARKET TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 37

4 PREMIUM INSIGHTS 38
4.1 PCR TECHNOLOGIES MARKET OVERVIEW 38
FIGURE 10 RISING INCIDENCE OF TARGET INFECTIOUS DISEASES AND GENETIC DISORDERS IS EXPECTED TO DRIVE MARKET GROWTH 38
4.2 PCR TECHNOLOGIES MARKET SHARE, BY TECHNIQUE, 2020 VS. 2025 39
FIGURE 11 REAL-TIME PCR SEGMENT ACCOUNTED FOR THE LARGEST SHARE
OF THE GLOBAL PCR TECHNOLOGIES MARKETS IN 2020 39
4.3 PCR TECHNOLOGIES MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION) 40
FIGURE 12 DIAGNOSTIC APPLICATIONS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 40
4.4 PCR TECHNOLOGIES MARKET, BY REGION, 2020–2025 41
FIGURE 13 APAC MARKET TO REGISTER THE HIGHEST GROWTH RATE DURING
THE FORECAST PERIOD 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
FIGURE 14 PCR TECHNOLOGIES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 42
5.2.1 KEY MARKET DRIVERS 42
5.2.1.1 Rising incidence of target infectious diseases and genetic disorders 42
FIGURE 15 GLOBAL BURDEN OF HIV INFECTIONS, BY REGION, 2017 43
FIGURE 16 GROWING GERIATRIC POPULATION ACROSS KEY GEOGRAPHIES,
2019 VS. 2050 (MILLION) 44
5.2.1.2 Continuous advancements in PCR technologies 44
FIGURE 17 TRADITIONAL PCR VS. QPCR AND DPCR 45
5.2.1.3 Increasing investments, funds, and grants 45
5.2.1.4 Increasing use of biomarker profiling for disease diagnostics 46
5.2.1.5 Successful completion of the human genome project 47
5.2.2 KEY MARKET RESTRAINTS 47
5.2.2.1 High device costs associated with dPCR 47
5.2.2.2 Technical limitations of qPCR and dPCR 47
5.2.3 KEY MARKET OPPORTUNITIES 48
5.2.3.1 Growing market penetration in emerging countries 48
5.2.3.2 Shift from plant-derived to genome-based drug discovery 48
5.2.4 KEY MARKET CHALLENGES 49
5.2.4.1 Adoption and implementation of MIQE guidelines 49
5.2.5 KEY MARKET TRENDS 49
5.2.5.1 Development of compact, portable, and lab-on-chip PCR devices 49
5.2.5.2 Ongoing technological integration with the PCR process 49
5.3 INDUSTRY TRENDS RELATED TO COVID-19 50
5.4 GLOBAL REGULATORY SCENARIO 50
5.5 ECOSYSTEM: PARENT MARKET 52
5.6 PORTER’S FIVE FORCES ANALYSIS 52
5.6.1 DEGREE OF COMPETITION 53
5.6.2 BARGAINING POWER OF SUPPLIERS 53
5.6.3 BARGAINING POWER OF BUYERS 53
5.6.4 THREAT OF NEW ENTRANTS 53
5.6.5 THREAT OF SUBSTITUTES 53
6 PCR TECHNOLOGIES MARKET, BY TECHNIQUE 54
6.1 INTRODUCTION 55
TABLE 1 PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 55
6.2 CONVENTIONAL PCR 55
6.2.1 HIGH ADOPTION OF THIS TECHNIQUE AND ITS DIVERSE APPLICATIONS
TO SUSTAIN MARKET GROWTH 55
TABLE 2 CONVENTIONAL PCR MARKET, BY REGION, 2018–2025 (USD MILLION) 56
TABLE 3 CONVENTIONAL PCR MARKET, BY PRODUCT TYPE,
2018–2025 (USD MILLION) 56
TABLE 4 CONVENTIONAL PCR MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 57
TABLE 5 CONVENTIONAL PCR MARKET, BY END USER, 2018–2025 (USD MILLION) 57
6.3 REAL-TIME PCR 58
6.3.1 GROWING ADOPTION AMONG RESEARCHERS AND HEALTHCARE PROFESSIONALS TO FUEL MARKET GROWTH 58
TABLE 6 REAL-TIME PCR MARKET, BY REGION, 2018–2025 (USD MILLION) 58
TABLE 7 REAL-TIME PCR MARKET, BY PRODUCT TYPE, 2018–2025 (USD MILLION) 59
TABLE 8 REAL-TIME PCR MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 59
TABLE 9 REAL-TIME PCR MARKET, BY END USER, 2018–2025 (USD MILLION) 60
6.4 DIGITAL PCR 60
6.4.1 ONGOING TECHNOLOGICAL DEVELOPMENTS WITH RESPECT TO DIGITAL
PCR TO DRIVE MARKET GROWTH 60
TABLE 10 DIGITAL PCR MARKET, BY REGION, 2018–2025 (USD MILLION) 61
TABLE 11 DIGITAL PCR MARKET, BY PRODUCT TYPE, 2018–2025 (USD MILLION) 61
TABLE 12 DIGITAL PCR MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 62
TABLE 13 DIGITAL PCR MARKET, BY END USER, 2018–2025 (USD MILLION) 62
6.5 REVERSE TRANSCRIPTION PCR 63
6.5.1 HIGHER SENSITIVITY FOR MRNA DETECTION IS A MAJOR CONTRIBUTING FACTOR TO MARKET GROWTH 63
TABLE 14 REVERSE TRANSCRIPTION PCR MARKET, BY REGION,
2018–2025 (USD MILLION) 63
TABLE 15 REVERSE TRANSCRIPTION PCR MARKET, BY PRODUCT TYPE,
2018–2025 (USD MILLION) 64
TABLE 16 REVERSE TRANSCRIPTION PCR MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 64
TABLE 17 REVERSE TRANSCRIPTION PCR MARKET, BY END USER,
2018–2025 (USD MILLION) 65
6.6 HOT-START PCR 65
6.6.1 HASSLE-FREE SETUP OF SAMPLES IS A KEY ADVANTAGE OFFERED
BY THIS TECHNIQUE 65
TABLE 18 HOT-START PCR MARKET, BY REGION, 2018–2025 (USD MILLION) 66
TABLE 19 HOT-START PCR MARKET, BY PRODUCT TYPE, 2018–2025 (USD MILLION) 66
TABLE 20 HOT-START PCR MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 67
TABLE 21 HOT-START PCR MARKET, BY END USER, 2018–2025 (USD MILLION) 67
6.7 MULTIPLEX PCR 68
6.7.1 COST-EFFECTIVENESS OF THIS TECHNIQUE TO DRIVE MARKET GROWTH 68
TABLE 22 MULTIPLEX PCR MARKET, BY REGION, 2018–2025 (USD MILLION) 68
TABLE 23 MULTIPLEX PCR MARKET, BY PRODUCT TYPE, 2018–2025 (USD MILLION) 69
TABLE 24 MULTIPLEX PCR MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 69
TABLE 25 MULTIPLEX PCR MARKET, BY END USER, 2018–2025 (USD MILLION) 70
6.8 OTHER PCR TECHNIQUES 70
TABLE 26 OTHER PCR TECHNIQUES MARKET, BY REGION, 2018–2025 (USD MILLION) 71
TABLE 27 OTHER PCR TECHNIQUES MARKET, BY PRODUCT TYPE,
2018–2025 (USD MILLION) 71
TABLE 28 OTHER PCR TECHNIQUES MARKET, BY APPLICATION,
2018–2025 (USD MILLION) 72
TABLE 29 OTHER PCR TECHNIQUES MARKET, BY END USER,
2018–2025 (USD MILLION) 72
7 PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE 73
7.1 INTRODUCTION 74
TABLE 30 PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE,
2018–2025 (USD MILLION) 74
7.2 INSTRUMENTS 74
7.2.1 INCREASING AVAILABILITY OF INNOVATIVE PCR INSTRUMENTS WILL
DRIVE MARKET GROWTH 74
TABLE 31 PCR INSTRUMENTS MARKET, BY REGION, 2018–2025 (USD MILLION) 75
7.3 REAGENTS AND CONSUMABLES 75
7.3.1 INCREASING NUMBER OF ANALYTICAL PROCEDURES AMONG RESEARCHERS TO FUEL MARKET GROWTH 75
TABLE 32 PCR REAGENTS AND CONSUMABLES MARKET, BY REGION,
2018–2025 (USD MILLION) 76
7.4 SOFTWARE AND SERVICES 76
7.4.1 AUTOMATION AND DIGITALIZATION OF LABORATORY PROCESSES TO
FUEL ADOPTION AMONG END USERS 76
TABLE 33 PCR SOFTWARE AND SERVICES MARKET, BY REGION,
2018–2025 (USD MILLION) 77
8 PCR TECHNOLOGIES MARKET, BY APPLICATION 78
8.1 INTRODUCTION 79
TABLE 34 PCR TECHNOLOGIES MARKET, BY APPLICATION, 2018–2025 (USD MILLION) 79
8.2 GENE EXPRESSION ANALYSIS 80
8.2.1 GENE EXPRESSION ANALYSIS IS USED IN EPIGENETICS, SIRNA QUANTIFICATION, MRNA ANALYSIS, AND CELL LINE VALIDATION 80
TABLE 35 PCR TECHNOLOGIES MARKET FOR GENE EXPRESSION ANALYSIS, BY REGION, 2018–2025 (USD MILLION) 80
8.3 GENETIC SEQUENCING 81
8.3.1 REDUCED COST OF SEQUENCING TO DRIVE MARKET GROWTH 81
TABLE 36 PCR TECHNOLOGIES MARKET FOR GENETIC SEQUENCING, BY REGION, 2018–2025 (USD MILLION) 81
8.4 GENOTYPING 82
8.4.1 SNP GENOTYPING CAN ACCELERATE THE ERA OF PERSONALIZED MEDICINE 82
TABLE 37 PCR TECHNOLOGIES MARKET FOR GENOTYPING, BY REGION,
2018–2025 (USD MILLION) 82
8.5 NUCLEIC ACID DETECTION 83
8.5.1 PCR TECHNIQUES HAVE WIDE APPLICATIONS IN NUCLEIC ACID DETECTION 83
TABLE 38 PCR TECHNOLOGIES MARKET FOR NUCLEIC ACID DETECTION, BY REGION, 2018–2025 (USD MILLION) 83
8.6 NUCLEIC ACID SYNTHESIS 84
8.6.1 DNA SYNTHESIS HAS OPENED AVENUES FOR PROGRESS IN BIOLOGY 84
TABLE 39 PCR TECHNOLOGIES MARKET FOR NUCLEIC ACID SYNTHESIS, BY REGION, 2018–2025 (USD MILLION) 84
8.7 STANDARD VALIDATION/VERIFICATION 84
8.7.1 PCR TECHNIQUES ARE USED FOR REGIONAL/GLOBAL VALIDATION TO FRAME COMMERCIAL/NON-COMMERCIAL GUIDELINES 84
TABLE 40 PCR TECHNOLOGIES MARKET FOR STANDARD VALIDATION/VERIFICATION, BY REGION, 2018–2025 (USD MILLION) 85
8.8 DIAGNOSTIC APPLICATIONS 85
8.8.1 DIAGNOSTIC APPLICATIONS SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE MARKET 85
TABLE 41 PCR TECHNOLOGIES MARKET FOR DIAGNOSTIC APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 86
8.9 ENVIRONMENTAL APPLICATIONS 86
8.9.1 PCR IS THE MOST SENSITIVE TECHNIQUE TO DETECT PATHOGENS
IN ENVIRONMENTAL SAMPLES 86
TABLE 42 PCR TECHNOLOGIES MARKET FOR ENVIRONMENTAL APPLICATIONS,
BY REGION, 2018–2025 (USD MILLION) 87
8.10 OTHER APPLICATIONS 87
TABLE 43 PCR TECHNOLOGIES MARKET FOR OTHER APPLICATIONS, BY REGION,
2018–2025 (USD MILLION) 87
9 PCR TECHNOLOGIES MARKET, BY END USER 88
9.1 INTRODUCTION 89
TABLE 44 PCR TECHNOLOGIES MARKET, BY END USER, 2018–2025 (USD MILLION) 89
9.2 HOSPITALS AND DIAGNOSTIC CENTERS 89
9.2.1 HIGH PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH 89
TABLE 45 PCR TECHNOLOGIES MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION, 2018–2025 (USD MILLION) 90
9.3 HEALTHCARE INDUSTRY 90
9.3.1 PCR HAS WIDE APPLICATIONS IN THE HEALTHCARE INDUSTRY 90
TABLE 46 PCR TECHNOLOGIES MARKET FOR HEALTHCARE INDUSTRY, BY REGION, 2018–2025 (USD MILLION) 91
9.4 ACADEMIA AND GOVERNMENT ORGANIZATIONS 91
9.4.1 AVAILABILITY OF COST-EFFECTIVE AND INNOVATIVE PCR PRODUCTS
TO DRIVE ADOPTION 91
TABLE 47 PCR TECHNOLOGIES MARKET FOR ACADEMIA AND GOVERNMENT ORGANIZATIONS, BY REGION, 2018–2025 (USD MILLION) 92
9.5 PHARMA-BIOTECH COMPANIES 92
9.5.1 INCREASING R&D INITIATIVES BY PHARMA-BIOTECH COMPANIES TO FUEL THE ADOPTION OF PCR TECHNOLOGIES 92
TABLE 48 PCR TECHNOLOGIES MARKET FOR PHARMA-BIOTECH COMPANIES,
BY REGION, 2018–2025 (USD MILLION) 93
9.6 APPLIED INDUSTRIES 93
9.6.1 INCREASING ENVIRONMENTAL REGULATIONS TO DRIVE THE ADOPTION
OF PCR TECHNIQUES 93
TABLE 49 PCR TECHNOLOGIES MARKET FOR APPLIED INDUSTRIES, BY REGION,
2018–2025 (USD MILLION) 94
9.7 OTHER END USERS 94
TABLE 50 PCR TECHNOLOGIES MARKET FOR OTHER END USERS, BY REGION,
2018–2025 (USD MILLION) 95
10 PCR TECHNOLOGIES MARKET, BY REGION 96
10.1 INTRODUCTION 97
TABLE 51 PCR TECHNOLOGIES MARKET, BY REGION, 2018–2025 (USD MILLION) 97
10.2 NORTH AMERICA 97
FIGURE 18 NORTH AMERICA: PCR TECHNOLOGIES MARKET SNAPSHOT 98
TABLE 52 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 99
TABLE 53 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 99
TABLE 54 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE,
2018–2025 (USD MILLION) 100
TABLE 55 NORTH AMERICA: PCR TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 100
10.2.1 US 101
10.2.1.1 Growing adoption of PCR techniques in research & academia
to drive market growth 101
TABLE 56 US: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 101
10.2.2 CANADA 102
10.2.2.1 Government initiatives for supporting genomics research to drive market growth in Canada 102
TABLE 57 CANADA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 102

10.3 EUROPE 103
TABLE 58 EUROPE: PCR TECHNOLOGIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 103
TABLE 59 EUROPE: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 104
TABLE 60 EUROPE: PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE,
2018–2025 (USD MILLION) 104
TABLE 61 EUROPE: PCR TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 105
10.3.1 GERMANY 105
10.3.1.1 Large-scale outsourcing of clinical diagnostic testing by
hospitals to drive market growth 105
TABLE 62 GERMANY: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 106
10.3.2 UK 106
10.3.2.1 Growing focus on genomics research to support market
growth in the UK 106
TABLE 63 UK: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 107
10.3.3 FRANCE 107
10.3.3.1 Initiatives for developing genomic medicine to support
market growth in France 107
TABLE 64 FRANCE: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 108
10.3.4 ITALY 108
10.3.4.1 Increasing R&D investments by pharmaceutical companies
to propel market growth 108
TABLE 65 ITALY: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 109
10.3.5 SPAIN 109
10.3.5.1 Increasing prevalence of chronic and infectious diseases to
drive market growth 109
TABLE 66 SPAIN: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 110
10.3.6 REST OF EUROPE 110
TABLE 67 REST OF EUROPE: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 111
10.4 ASIA PACIFIC 111
FIGURE 19 ASIA PACIFIC: PCR TECHNOLOGIES MARKET SNAPSHOT 112
TABLE 68 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 113
TABLE 69 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 113
TABLE 70 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE,
2018–2025 (USD MILLION) 114
TABLE 71 ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 114
10.4.1 JAPAN 114
10.4.1.1 Strong research and healthcare infrastructure to support
market growth in Japan 114
TABLE 72 JAPAN: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 115
10.4.2 CHINA 115
10.4.2.1 Healthcare infrastructure modernization to support market
growth in China 115
TABLE 73 CHINA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 116
10.4.3 INDIA 116
10.4.3.1 Presence of a large target patient population to support market growth in India 116
TABLE 74 INDIA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 117
10.4.4 AUSTRALIA 117
10.4.4.1 High healthcare expenditure in the country to support market growth 117
TABLE 75 AUSTRALIA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 118
10.4.5 SOUTH KOREA 118
10.4.5.1 Growing number of private hospitals and independent testing laboratories to drive market growth 118
TABLE 76 SOUTH KOREA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 119
10.4.6 REST OF ASIA PACIFIC 119
TABLE 77 REST OF ASIA PACIFIC: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 120
10.5 LATIN AMERICA 120
TABLE 78 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY COUNTRY,
2018–2025 (USD MILLION) 120
TABLE 79 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 121
TABLE 80 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE,
2018–2025 (USD MILLION) 121
TABLE 81 LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY END USER,
2018–2025 (USD MILLION) 122
10.5.1 BRAZIL 122
10.5.1.1 Brazil is expected to dominate the LATAM market 122
TABLE 82 BRAZIL: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 123
10.5.2 MEXICO 123
10.5.2.1 Favorable trade agreements will support imports and improve the accessibility to PCR instruments in Mexico 123
TABLE 83 MEXICO: PCR TECHNOLOGIES MARKET, BY TECHNIQUE,
2018–2025 (USD MILLION) 124
10.5.3 REST OF LATIN AMERICA 124
TABLE 84 REST OF LATIN AMERICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 124
10.6 MIDDLE EAST AND AFRICA 125
10.6.1 LOW PURCHASING POWER OF END USERS AND INFRASTRUCTURAL LIMITATIONS TO RESTRAIN MARKET GROWTH IN THE MEA 125
TABLE 85 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY TECHNIQUE, 2018–2025 (USD MILLION) 125
TABLE 86 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY PRODUCT TYPE, 2018–2025 (USD MILLION) 126
TABLE 87 MIDDLE EAST & AFRICA: PCR TECHNOLOGIES MARKET, BY END USER, 2018–2025 (USD MILLION) 126
11 COMPETITIVE LANDSCAPE 127
11.1 OVERVIEW 127
FIGURE 20 KEY DEVELOPMENTS BY LEADING PLAYERS IN THE PCR TECHNOLOGIES MARKET, 2017–2020 128
11.2 GLOBAL MARKET SHARE ANALYSIS 129
11.2.1 GLOBAL PCR TECHNOLOGIES MARKET SHARE ANALYSIS (2019) 129
FIGURE 21 GLOBAL PCR TECHNOLOGIES MARKET SHARE ANALYSIS,
BY KEY PLAYER (2019) 129
11.3 COMPETITIVE LEADERSHIP MAPPING 130
11.3.1 STARS 130
11.3.2 EMERGING LEADERS 130
11.3.3 PERVASIVE 131
11.3.4 PARTICIPANTS 131
FIGURE 22 PCR TECHNOLOGIES MARKET: COMPETITIVE LEADERSHIP MAPPING (2019) 131
FIGURE 23 PCR TECHNOLOGIES MARKET: COMPETITIVE LEADERSHIP MAPPING (SME/START-UPS) 132
11.4 COMPETITIVE SCENARIO 133
TABLE 88 PCR TECHNOLOGIES MARKET: PRODUCT LAUNCHES AND
APPROVALS, 2017–2020 133
TABLE 89 PCR TECHNOLOGIES MARKET: EXPANSIONS, 2017–2020 133
TABLE 90 PCR TECHNOLOGIES MARKET: ACQUISITIONS, 2017–2020 134
12 COMPANY PROFILES 135
12.1 KEY PLAYERS 135
(Business Overview, Products & services offered, Recent Developments, SWOT Analysis, MnM View)*
12.1.1 THERMO FISHER SCIENTIFIC, INC. 135
TABLE 91 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 135
FIGURE 24 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2019) 136
TABLE 92 THERMO FISHER SCIENTIFIC, INC.: PRODUCTS & SERVICES OFFERED 136
12.1.2 F. HOFFMAN-LA ROCHE LTD. 141
TABLE 93 F. HOFFMAN-LA ROCHE LTD.: BUSINESS OVERVIEW 141
FIGURE 25 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2019) 142
TABLE 94 EXCHANGE RATES (UTILIZED FOR CONVERSION OF CHF TO USD) 142
TABLE 95 ROCHE DIAGNOSTICS: PRODUCTS & SERVICES OFFERED 142
12.1.3 BIO-RAD LABORATORIES, INC. 146
TABLE 96 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 146
FIGURE 26 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2019) 146
TABLE 97 BIO-RAD LABORATORIES, INC.: PRODUCTS AND SERVICES OFFERED 147
12.1.4 QIAGEN N.V. 150
TABLE 98 QIAGEN N.V.: BUSINESS OVERVIEW 150
FIGURE 27 QIAGEN N.V.: COMPANY SNAPSHOT (2019) 150
TABLE 99 QIAGEN N.V.: PRODUCTS OFFERED 151
12.1.5 TAKARA BIO, INC. 154
TABLE 100 TAKARA BIO, INC.: BUSINESS OVERVIEW 154
FIGURE 28 TAKARA BIO, INC.: COMPANY SNAPSHOT (2019) 154
TABLE 101 EXCHANGE RATES (UTILIZED FOR CONVERSION OF JPY TO USD) 155
TABLE 102 TAKARA BIO, INC.: PRODUCTS OFFERED 155
12.1.6 AGILENT TECHNOLOGIES, INC. 157
TABLE 103 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 157
FIGURE 29 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2019) 158
TABLE 104 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED 158
12.1.7 BIOMÉRIEUX S.A. 163
TABLE 105 BIOMÉRIEUX S.A.: BUSINESS OVERVIEW 163
FIGURE 30 BIOMÉRIEUX S.A.: COMPANY SNAPSHOT (2019) 164
TABLE 106 EXCHANGE RATES (UTILIZED FOR CONVERSION OF EUR TO USD) 164
TABLE 107 BIOMÉRIEUX: PRODUCTS OFFERED 164
12.1.8 FLUIDIGM CORPORATION 166
TABLE 108 FLUIDIGM CORPORATION: BUSINESS OVERVIEW 166
FIGURE 31 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2019) 166
TABLE 109 FLUIDIGM CORPORATION: PRODUCTS OFFERED 167
12.1.9 DANAHER CORPORATION 169
TABLE 110 DANAHER CORPORATION: BUSINESS OVERVIEW 169
FIGURE 32 DANAHER CORPORATION: COMPANY SNAPSHOT (2019) 169
TABLE 111 DANAHER CORPORATION: PRODUCTS OFFERED 170
12.1.10 ABBOTT LABORATORIES 172
TABLE 112 ABBOTT LABORATORIES: BUSINESS OVERVIEW 172
FIGURE 33 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019) 172
TABLE 113 ABBOTT LABORATORIES: PRODUCTS OFFERED 173
12.2 OTHER PLAYERS 176
12.2.1 MERCK KGAA 176
TABLE 114 MERCK KGAA: BUSINESS OVERVIEW 176
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2019) 176
TABLE 115 EXCHANGE RATES (UTILIZED FOR CONVERSION OF EUR TO USD) 177
TABLE 116 MERCK KGAA: PRODUCTS & SERVICES OFFERED 177
12.2.2 BECTON, DICKINSON AND COMPANY 179
TABLE 117 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 179
FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2019) 180
TABLE 118 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 180
12.2.3 PROMEGA CORPORATION 182
TABLE 119 PROMEGA CORPORATION: BUSINESS OVERVIEW 182
TABLE 120 PROMEGA CORPORATION: PRODUCTS OFFERED 182
12.2.4 EPPENDORF AG 185
TABLE 121 EPPENDORF AG: BUSINESS OVERVIEW 185
FIGURE 36 EPPENDORF AG: COMPANY SNAPSHOT (2019) 185
TABLE 122 EXCHANGE RATES (UTILIZED FOR THE CONVERSION OF EUR TO USD) 185
TABLE 123 EPPENDORF AG: PRODUCTS OFFERED 186
12.2.5 ANALYTIK JENA AG (A WHOLLY OWNED SUBSIDIARY OF
ENDRESS+HAUSER AG) 187
TABLE 124 ENDRESS+HAUSER: BUSINESS OVERVIEW 187
FIGURE 37 ENDRESS+HAUSER AG: COMPANY SNAPSHOT (2019) 188
TABLE 125 EXCHANGE RATES (UTILIZED FOR CONVERSION OF EUR TO USD) 188
TABLE 126 ANALYTIK JENA AG: PRODUCTS OFFERED 189
*Details on Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View might not be captured in case of unlisted companies.
13 APPENDIX 190
13.1 DISCUSSION GUIDE 190
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 195
13.3 AVAILABLE CUSTOMIZATIONS 197
13.4 RELATED REPORTS 197
13.5 AUTHOR DETAILS 199



★調査レポート[世界のPCR技術市場予測:技術別、製品別、用途別、エンドユーザー別] ( PCR Technologies Market by Technology (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene expression, diagnostics), Enduser (Academia, pharma-biotech, applied)-Global Forecast to 2025 / AST7880) 販売に関する免責事項
[世界のPCR技術市場予測:技術別、製品別、用途別、エンドユーザー別] ( PCR Technologies Market by Technology (Conventional, qPCR, dPCR), Product (Instrument, Reagents, Software), Application (Genotyping, Sequencing, Gene expression, diagnostics), Enduser (Academia, pharma-biotech, applied)-Global Forecast to 2025 / AST7880) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆